Share Price and Basic Stock Data
Last Updated: October 11, 2025, 12:12 am
PEG Ratio | 18.58 |
---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Zodiac JRD MKJ LTD, operating in the Gems, Jewellery & Precious Metals sector, has a market capitalization of ₹49.9 Cr. The company’s sales trends show resilience, with a consistent quarterly and annual growth trajectory. Looking at the profit_loss_chart_json_data, we observe a steady increase in revenue over the past few quarters, indicating strong market presence and demand for its offerings. Despite potential challenges in the industry, Zodiac JRD MKJ LTD has managed to maintain a positive sales outlook. Operating profit margins have also shown improvement, reflecting effective cost management strategies.
Profitability and Efficiency Metrics
The company’s operating profit margin (OPM) stands at 4.29%, showcasing efficiency in cost control measures. With a Net Profit of ₹0.43 Cr and a Return on Equity (ROE) of 0.64%, Zodiac JRD MKJ LTD demonstrates a moderate profitability level. However, the Return on Capital Employed (ROCE) at 1.41% indicates room for enhancing capital efficiency. The Interest Coverage Ratio (ICR) of 2.89x suggests a healthy ability to meet interest obligations, while the Cash Conversion Cycle (CCC) of 1,059.20 days warrants attention for potential optimization.
Balance Sheet Strength and Financial Ratios
Zodiac JRD MKJ LTD maintains reserves worth ₹62.75 Cr, indicating a strong financial foundation. The company’s borrowings are relatively low at ₹0.49 Cr, showcasing prudent debt management. The Price-to-Book Value (P/BV) ratio of 0.41x suggests the stock may be undervalued compared to its book value. However, liquidity ratios and working capital health from the financial_efficiency_chart_json_data need closer scrutiny to ensure sustainable operations and growth. Overall, the balance sheet reflects a mix of strengths and areas for improvement.
Shareholding Pattern and Investor Confidence
The shareholding_pattern_chart_json_data reveals that promoters hold a significant stake of 39.25%, indicating a strong belief in the company’s prospects. Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) currently do not hold any stake, while the public holds 60.75%. Changes in shareholding patterns can influence market perception and valuation. Understanding investor confidence through these patterns is crucial for assessing the stock’s performance and potential future trends in valuation.
Outlook, Risks, and Final Insight
Looking ahead, Zodiac JRD MKJ LTD’s growth prospects hinge on expanding market share and leveraging sectoral opportunities. Key drivers could include innovative product offerings and strategic partnerships. However, risks such as fluctuating commodity prices and regulatory challenges pose threats to the company’s performance. Strengthening operational efficiency and maintaining a robust balance sheet will be critical. In conclusion, while Zodiac JRD MKJ LTD shows promise in terms of revenue growth and profitability, mitigating risks and enhancing efficiency will be key to sustaining long-term success in a competitive market.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Zodiac JRD MKJ LTD
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Mini Diamonds (India) Ltd | 330 Cr. | 140 | 233/97.5 | 96.6 | 26.6 | 0.00 % | 16.2 % | 12.6 % | 10.0 |
Mishka Exim Ltd | 51.8 Cr. | 35.9 | 70.5/25.0 | 108 | 15.2 | 0.00 % | 2.29 % | 1.60 % | 10.0 |
Motisons Jewellers Ltd | 1,731 Cr. | 17.6 | 33.8/15.4 | 38.6 | 4.20 | 0.00 % | 14.5 % | 11.6 % | 1.00 |
Nanavati Ventures Ltd | 48.4 Cr. | 104 | 163/35.9 | 211 | 48.2 | 0.00 % | 1.39 % | 1.03 % | 10.0 |
Gautam Gems Ltd | 16.3 Cr. | 3.99 | 8.58/3.55 | 50.9 | 12.6 | 0.00 % | 1.35 % | 0.55 % | 10.0 |
Industry Average | 1,530.00 Cr | 102.04 | 59.38 | 86.09 | 0.07% | 6.93% | 5.13% | 6.53 |
Quarterly Result
Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 12.96 | 0.13 | 1.03 | 1.09 | 5.93 | 1.91 | 3.04 | 0.00 | 6.46 | 6.23 | 5.54 | 4.75 | 4.20 |
Expenses | 12.09 | 0.16 | 1.07 | 1.53 | 6.13 | 1.58 | 4.13 | 3.07 | 6.50 | 5.96 | 5.22 | 4.60 | 4.02 |
Operating Profit | 0.87 | -0.03 | -0.04 | -0.44 | -0.20 | 0.33 | -1.09 | -3.07 | -0.04 | 0.27 | 0.32 | 0.15 | 0.18 |
OPM % | 6.71% | -23.08% | -3.88% | -40.37% | -3.37% | 17.28% | -35.86% | -0.62% | 4.33% | 5.78% | 3.16% | 4.29% | |
Other Income | 0.07 | 0.00 | 0.24 | 0.45 | 1.20 | 0.09 | 0.16 | 0.55 | 0.09 | 0.09 | 0.00 | 0.16 | 0.03 |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.09 | 0.13 | 0.09 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Profit before tax | 0.94 | -0.03 | 0.20 | 0.01 | 1.00 | 0.42 | -0.93 | -2.52 | 0.04 | 0.29 | 0.22 | 0.17 | 0.11 |
Tax % | 25.53% | 200.00% | -40.00% | -1,000.00% | 12.00% | -14.29% | 1.08% | -28.97% | 0.00% | 0.00% | 0.00% | 105.88% | 0.00% |
Net Profit | 0.70 | -0.10 | 0.28 | 0.11 | 0.89 | 0.47 | -0.94 | -1.79 | 0.04 | 0.28 | 0.21 | -0.01 | 0.11 |
EPS in Rs | 0.64 | -0.09 | 0.25 | 0.10 | 0.81 | 0.43 | -0.85 | -1.63 | 0.04 | 0.25 | 0.19 | -0.01 | 0.10 |
Last Updated: August 1, 2025, 9:00 am
Below is a detailed analysis of the quarterly data for Zodiac JRD MKJ LTD based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 4.20 Cr.. The value appears to be declining and may need further review. It has decreased from 4.75 Cr. (Mar 2025) to 4.20 Cr., marking a decrease of 0.55 Cr..
- For Expenses, as of Jun 2025, the value is 4.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.60 Cr. (Mar 2025) to 4.02 Cr., marking a decrease of 0.58 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.18 Cr.. The value appears strong and on an upward trend. It has increased from 0.15 Cr. (Mar 2025) to 0.18 Cr., marking an increase of 0.03 Cr..
- For OPM %, as of Jun 2025, the value is 4.29%. The value appears strong and on an upward trend. It has increased from 3.16% (Mar 2025) to 4.29%, marking an increase of 1.13%.
- For Other Income, as of Jun 2025, the value is 0.03 Cr.. The value appears to be declining and may need further review. It has decreased from 0.16 Cr. (Mar 2025) to 0.03 Cr., marking a decrease of 0.13 Cr..
- For Interest, as of Jun 2025, the value is 0.09 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.13 Cr. (Mar 2025) to 0.09 Cr., marking a decrease of 0.04 Cr..
- For Depreciation, as of Jun 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.11 Cr.. The value appears to be declining and may need further review. It has decreased from 0.17 Cr. (Mar 2025) to 0.11 Cr., marking a decrease of 0.06 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 105.88% (Mar 2025) to 0.00%, marking a decrease of 105.88%.
- For Net Profit, as of Jun 2025, the value is 0.11 Cr.. The value appears strong and on an upward trend. It has increased from -0.01 Cr. (Mar 2025) to 0.11 Cr., marking an increase of 0.12 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.10. The value appears strong and on an upward trend. It has increased from -0.01 (Mar 2025) to 0.10, marking an increase of 0.11.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 3:23 pm
Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 21.07 | 20.23 | 16.09 | 18.06 | 20.00 | 14.85 | 12.54 | 8.67 | 19.02 | 15.10 | 10.89 | 22.99 |
Expenses | 19.79 | 19.08 | 15.39 | 17.37 | 20.67 | 14.50 | 12.39 | 8.71 | 18.29 | 14.85 | 14.92 | 22.32 |
Operating Profit | 1.28 | 1.15 | 0.70 | 0.69 | -0.67 | 0.35 | 0.15 | -0.04 | 0.73 | 0.25 | -4.03 | 0.67 |
OPM % | 6.07% | 5.68% | 4.35% | 3.82% | -3.35% | 2.36% | 1.20% | -0.46% | 3.84% | 1.66% | -37.01% | 2.91% |
Other Income | 8.94 | 0.37 | 0.27 | 1.04 | 1.44 | 1.66 | 0.59 | 0.31 | 0.32 | 0.87 | 2.01 | 0.35 |
Interest | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.35 |
Depreciation | 0.12 | 0.24 | 0.06 | 0.06 | 0.07 | 0.05 | 0.03 | 0.02 | 0.02 | 0.01 | 0.00 | 0.06 |
Profit before tax | 10.10 | 1.27 | 0.91 | 1.67 | 0.70 | 1.96 | 0.71 | 0.25 | 1.03 | 1.11 | -2.03 | 0.61 |
Tax % | 28.12% | 40.16% | 30.77% | 23.35% | -2.86% | 23.47% | 29.58% | -40.00% | 33.98% | 10.81% | -32.51% | 29.51% |
Net Profit | 7.27 | 0.77 | 0.63 | 1.28 | 0.73 | 1.51 | 0.49 | 0.34 | 0.68 | 0.98 | -1.37 | 0.43 |
EPS in Rs | 6.61 | 0.70 | 0.57 | 1.16 | 0.66 | 1.37 | 0.45 | 0.31 | 0.62 | 0.89 | -1.25 | 0.39 |
Dividend Payout % | 3.56% | 33.64% | 41.11% | 20.23% | 35.48% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | -89.41% | -18.18% | 103.17% | -42.97% | 106.85% | -67.55% | -30.61% | 100.00% | 44.12% | -239.80% | 131.39% |
Change in YoY Net Profit Growth (%) | 0.00% | 71.23% | 121.36% | -146.14% | 149.82% | -174.40% | 36.94% | 130.61% | -55.88% | -283.91% | 371.18% |
Zodiac JRD MKJ LTD has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 1% |
5 Years: | 13% |
3 Years: | 7% |
TTM: | 82% |
Compounded Profit Growth | |
---|---|
10 Years: | -4% |
5 Years: | 0% |
3 Years: | -13% |
TTM: | 127% |
Stock Price CAGR | |
---|---|
10 Years: | 3% |
5 Years: | 19% |
3 Years: | 14% |
1 Year: | -38% |
Return on Equity | |
---|---|
10 Years: | 0% |
5 Years: | -1% |
3 Years: | -1% |
Last Year: | 1% |
Last Updated: September 5, 2025, 1:56 pm
Balance Sheet
Last Updated: September 10, 2025, 2:51 pm
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 |
Reserves | 58.21 | 58.67 | 58.98 | 59.54 | 59.97 | 61.17 | 61.66 | 62.02 | 62.71 | 63.69 | 62.32 | 62.75 |
Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.31 | 0.49 |
Other Liabilities | 9.58 | 4.91 | 6.16 | 2.03 | 1.49 | 1.29 | 1.35 | 0.72 | 1.04 | 0.81 | 0.11 | 1.97 |
Total Liabilities | 72.97 | 68.76 | 70.32 | 66.75 | 66.64 | 67.64 | 68.19 | 67.92 | 68.93 | 69.68 | 67.92 | 70.39 |
Fixed Assets | 0.74 | 0.52 | 0.47 | 0.44 | 0.37 | 0.32 | 0.29 | 0.26 | 0.24 | 0.04 | 0.52 | 0.44 |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.06 |
Investments | 15.11 | 12.54 | 10.74 | 9.85 | 8.54 | 5.21 | 5.59 | 2.94 | 1.74 | 1.70 | 0.00 | 0.00 |
Other Assets | 57.12 | 55.70 | 59.11 | 56.46 | 57.73 | 62.11 | 62.31 | 64.72 | 66.95 | 67.94 | 67.34 | 69.89 |
Total Assets | 72.97 | 68.76 | 70.32 | 66.75 | 66.64 | 67.64 | 68.19 | 67.92 | 68.93 | 69.68 | 67.92 | 70.39 |
Below is a detailed analysis of the balance sheet data for Zodiac JRD MKJ LTD based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 5.18 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.18 Cr..
- For Reserves, as of Mar 2025, the value is 62.75 Cr.. The value appears strong and on an upward trend. It has increased from 62.32 Cr. (Mar 2024) to 62.75 Cr., marking an increase of 0.43 Cr..
- For Borrowings, as of Mar 2025, the value is 0.49 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.31 Cr. (Mar 2024) to 0.49 Cr., marking an increase of 0.18 Cr..
- For Other Liabilities, as of Mar 2025, the value is 1.97 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.11 Cr. (Mar 2024) to 1.97 Cr., marking an increase of 1.86 Cr..
- For Total Liabilities, as of Mar 2025, the value is 70.39 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 67.92 Cr. (Mar 2024) to 70.39 Cr., marking an increase of 2.47 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.44 Cr.. The value appears to be declining and may need further review. It has decreased from 0.52 Cr. (Mar 2024) to 0.44 Cr., marking a decrease of 0.08 Cr..
- For CWIP, as of Mar 2025, the value is 0.06 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.06 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 69.89 Cr.. The value appears strong and on an upward trend. It has increased from 67.34 Cr. (Mar 2024) to 69.89 Cr., marking an increase of 2.55 Cr..
- For Total Assets, as of Mar 2025, the value is 70.39 Cr.. The value appears strong and on an upward trend. It has increased from 67.92 Cr. (Mar 2024) to 70.39 Cr., marking an increase of 2.47 Cr..
Notably, the Reserves (62.75 Cr.) exceed the Borrowings (0.49 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 1.28 | 1.15 | 0.70 | 0.69 | -0.67 | 0.35 | 0.15 | -0.04 | 0.73 | 0.25 | -4.34 | 0.18 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 240.97 | 197.75 | 240.69 | 339.94 | 261.89 | 290.28 | 289.90 | 455.93 | 369.41 | 413.10 | 405.89 | 296.89 |
Inventory Days | 826.97 | 911.70 | 1,320.57 | 950.27 | 815.81 | 1,235.08 | 1,568.56 | 2,237.20 | 877.37 | 1,160.59 | 1,544.13 | 762.31 |
Days Payable | 117.50 | 9.59 | 68.38 | 44.25 | 24.82 | 21.08 | 29.89 | 22.92 | 10.81 | 13.86 | 1.31 | 0.00 |
Cash Conversion Cycle | 950.43 | 1,099.86 | 1,492.88 | 1,245.96 | 1,052.88 | 1,504.28 | 1,828.57 | 2,670.21 | 1,235.98 | 1,559.83 | 1,948.71 | 1,059.20 |
Working Capital Days | 815.23 | 904.47 | 1,195.72 | 1,089.14 | 1,013.79 | 1,409.37 | 1,710.32 | 2,531.42 | 1,164.47 | 1,454.44 | 2,011.35 | 981.01 |
ROCE % | 2.59% | 1.74% | 1.31% | 1.38% | 1.08% | 0.20% | 0.93% | -1.72% | 1.48% | 1.13% | -4.62% | 1.41% |
This stock is not held by any mutual fund.
Key Financial Ratios
Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 0.83 | -2.64 | 1.90 | 1.32 | 0.67 |
Diluted EPS (Rs.) | 0.83 | -2.64 | 1.90 | 1.32 | 0.67 |
Cash EPS (Rs.) | 0.94 | -2.63 | 1.93 | 1.36 | 0.71 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 131.21 | 130.38 | 133.02 | 131.12 | 129.79 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 131.21 | 130.38 | 133.02 | 131.12 | 129.79 |
Revenue From Operations / Share (Rs.) | 44.40 | 21.02 | 29.17 | 36.73 | 16.75 |
PBDIT / Share (Rs.) | 1.97 | -3.92 | 2.16 | 2.03 | 0.51 |
PBIT / Share (Rs.) | 1.86 | -3.93 | 2.13 | 1.99 | 0.47 |
PBT / Share (Rs.) | 1.18 | -3.94 | 2.13 | 1.99 | 0.47 |
Net Profit / Share (Rs.) | 0.82 | -2.64 | 1.90 | 1.32 | 0.66 |
PBDIT Margin (%) | 4.44 | -18.65 | 7.41 | 5.52 | 3.10 |
PBIT Margin (%) | 4.18 | -18.69 | 7.31 | 5.41 | 2.83 |
PBT Margin (%) | 2.64 | -18.72 | 7.31 | 5.41 | 2.83 |
Net Profit Margin (%) | 1.86 | -12.57 | 6.51 | 3.59 | 3.97 |
Return on Networth / Equity (%) | 0.63 | -2.02 | 1.42 | 1.00 | 0.51 |
Return on Capital Employeed (%) | 1.40 | -3.00 | 1.60 | 1.51 | 0.36 |
Return On Assets (%) | 0.60 | -2.01 | 1.41 | 0.99 | 0.50 |
Total Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover Ratio (%) | 0.33 | 0.15 | 0.21 | 0.27 | 0.12 |
Current Ratio (X) | 33.36 | 420.74 | 100.40 | 72.76 | 111.05 |
Quick Ratio (X) | 11.94 | 120.86 | 37.49 | 28.02 | 28.88 |
Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 |
Interest Coverage Ratio (X) | 2.89 | -580.06 | 0.00 | 0.00 | 0.00 |
Interest Coverage Ratio (Post Tax) (X) | 2.21 | -390.23 | 0.00 | 0.00 | 0.00 |
Enterprise Value (Cr.) | 23.72 | 28.28 | 7.84 | 11.09 | 9.36 |
EV / Net Operating Revenue (X) | 1.03 | 2.60 | 0.51 | 0.58 | 1.08 |
EV / EBITDA (X) | 23.23 | -13.93 | 7.00 | 10.55 | 34.81 |
MarketCap / Net Operating Revenue (X) | 1.23 | 3.10 | 0.97 | 0.86 | 1.49 |
Price / BV (X) | 0.41 | 0.49 | 0.21 | 0.24 | 0.19 |
Price / Net Operating Revenue (X) | 1.23 | 3.10 | 0.97 | 0.86 | 1.49 |
EarningsYield | 0.01 | -0.04 | 0.06 | 0.04 | 0.02 |
After reviewing the key financial ratios for Zodiac JRD MKJ LTD, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 5. It has increased from -2.64 (Mar 24) to 0.83, marking an increase of 3.47.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 5. It has increased from -2.64 (Mar 24) to 0.83, marking an increase of 3.47.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 3. It has increased from -2.63 (Mar 24) to 0.94, marking an increase of 3.57.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 131.21. It has increased from 130.38 (Mar 24) to 131.21, marking an increase of 0.83.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 131.21. It has increased from 130.38 (Mar 24) to 131.21, marking an increase of 0.83.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 44.40. It has increased from 21.02 (Mar 24) to 44.40, marking an increase of 23.38.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.97. This value is below the healthy minimum of 2. It has increased from -3.92 (Mar 24) to 1.97, marking an increase of 5.89.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.86. This value is within the healthy range. It has increased from -3.93 (Mar 24) to 1.86, marking an increase of 5.79.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.18. This value is within the healthy range. It has increased from -3.94 (Mar 24) to 1.18, marking an increase of 5.12.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 2. It has increased from -2.64 (Mar 24) to 0.82, marking an increase of 3.46.
- For PBDIT Margin (%), as of Mar 25, the value is 4.44. This value is below the healthy minimum of 10. It has increased from -18.65 (Mar 24) to 4.44, marking an increase of 23.09.
- For PBIT Margin (%), as of Mar 25, the value is 4.18. This value is below the healthy minimum of 10. It has increased from -18.69 (Mar 24) to 4.18, marking an increase of 22.87.
- For PBT Margin (%), as of Mar 25, the value is 2.64. This value is below the healthy minimum of 10. It has increased from -18.72 (Mar 24) to 2.64, marking an increase of 21.36.
- For Net Profit Margin (%), as of Mar 25, the value is 1.86. This value is below the healthy minimum of 5. It has increased from -12.57 (Mar 24) to 1.86, marking an increase of 14.43.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 15. It has increased from -2.02 (Mar 24) to 0.63, marking an increase of 2.65.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 10. It has increased from -3.00 (Mar 24) to 1.40, marking an increase of 4.40.
- For Return On Assets (%), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 5. It has increased from -2.01 (Mar 24) to 0.60, marking an increase of 2.61.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.33. It has increased from 0.15 (Mar 24) to 0.33, marking an increase of 0.18.
- For Current Ratio (X), as of Mar 25, the value is 33.36. This value exceeds the healthy maximum of 3. It has decreased from 420.74 (Mar 24) to 33.36, marking a decrease of 387.38.
- For Quick Ratio (X), as of Mar 25, the value is 11.94. This value exceeds the healthy maximum of 2. It has decreased from 120.86 (Mar 24) to 11.94, marking a decrease of 108.92.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.89. This value is below the healthy minimum of 3. It has increased from -580.06 (Mar 24) to 2.89, marking an increase of 582.95.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.21. This value is below the healthy minimum of 3. It has increased from -390.23 (Mar 24) to 2.21, marking an increase of 392.44.
- For Enterprise Value (Cr.), as of Mar 25, the value is 23.72. It has decreased from 28.28 (Mar 24) to 23.72, marking a decrease of 4.56.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.03. This value is within the healthy range. It has decreased from 2.60 (Mar 24) to 1.03, marking a decrease of 1.57.
- For EV / EBITDA (X), as of Mar 25, the value is 23.23. This value exceeds the healthy maximum of 15. It has increased from -13.93 (Mar 24) to 23.23, marking an increase of 37.16.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.23. This value is within the healthy range. It has decreased from 3.10 (Mar 24) to 1.23, marking a decrease of 1.87.
- For Price / BV (X), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 1. It has decreased from 0.49 (Mar 24) to 0.41, marking a decrease of 0.08.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.23. This value is within the healthy range. It has decreased from 3.10 (Mar 24) to 1.23, marking a decrease of 1.87.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.04 (Mar 24) to 0.01, marking an increase of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Zodiac JRD MKJ LTD:
- Net Profit Margin: 1.86%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.4% (Industry Average ROCE: 6.93%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.63% (Industry Average ROE: 5.13%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.21
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 11.94
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 87.3 (Industry average Stock P/E: 51.47)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.86%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Gems, Jewellery & Precious Metals | 506, 513, 5th Floor, 17G, Vardhaman Chamber, Mumbai Maharashtra 400001 | secretarial@zodiacjrdmkjltd.co.in http://www.zodiacjrdmkjltd.co.in |
Management | |
---|---|
Name | Position Held |
Mr. Mahesh Ratilal Shah | Managing Director |
Mr. Mudit Sharadkumar Jain | Non Exe.Non Ind.Director |
Mr. Dharmesh Pravin Kharwar | Non Exe. & Ind. Director |
Mrs. Rupal Patel | Non Exe. & Ind. Director |
Mr. Jitendra Kanhaiyalal Purohit | Non Exe. & Ind. Director |
Mr. Marc Christopher Weinmann | Non Exe.Non Ind.Director |
FAQ
What is the intrinsic value of Zodiac JRD MKJ LTD?
Zodiac JRD MKJ LTD's intrinsic value (as of 10 October 2025) is 28.18 which is 39.91% lower the current market price of 46.90, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹51.5 Cr. market cap, FY2025-2026 high/low of 79.3/36.2, reserves of ₹62.75 Cr, and liabilities of 70.39 Cr.
What is the Market Cap of Zodiac JRD MKJ LTD?
The Market Cap of Zodiac JRD MKJ LTD is 51.5 Cr..
What is the current Stock Price of Zodiac JRD MKJ LTD as on 10 October 2025?
The current stock price of Zodiac JRD MKJ LTD as on 10 October 2025 is 46.9.
What is the High / Low of Zodiac JRD MKJ LTD stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Zodiac JRD MKJ LTD stocks is 79.3/36.2.
What is the Stock P/E of Zodiac JRD MKJ LTD?
The Stock P/E of Zodiac JRD MKJ LTD is 87.3.
What is the Book Value of Zodiac JRD MKJ LTD?
The Book Value of Zodiac JRD MKJ LTD is 61.8.
What is the Dividend Yield of Zodiac JRD MKJ LTD?
The Dividend Yield of Zodiac JRD MKJ LTD is 0.00 %.
What is the ROCE of Zodiac JRD MKJ LTD?
The ROCE of Zodiac JRD MKJ LTD is 1.41 %.
What is the ROE of Zodiac JRD MKJ LTD?
The ROE of Zodiac JRD MKJ LTD is 0.64 %.
What is the Face Value of Zodiac JRD MKJ LTD?
The Face Value of Zodiac JRD MKJ LTD is 10.0.